Supplemental material
Emerging Microbes & Infections
Volume 13, 2024 - Issue 1
Open access
982
Views
0
CrossRef citations to date
0
Altmetric
Non-neutralizing protective antibodies
Neutralizing and enhancing monoclonal antibodies in SARS-CoV-2 convalescent patients: lessons from early variant infection and impact on shaping emerging variants
Frédéric Coutanta Immunogenomics and Inflammation Research Team, University of Lyon, Edouard Herriot Hospital, Lyon, France;b Immunology Department, Lyon-Sud Hospital, Hospices Civils of Lyon, Pierre-Bénite, FranceCorrespondence[email protected]
https://orcid.org/0000-0003-2485-5284View further author information
, https://orcid.org/0000-0003-2485-5284View further author information
Franck Touretc Unité des Virus Émergents (UVE: Aix-Marseille University - IRD 190 - Inserm 1207), Marseille, Francehttps://orcid.org/0000-0002-4734-2249View further author information
, Jean-Jacques Pind Eurobio Scientific/Dendritics – Edouard Herriot Hospital, Lyon, FranceView further author information
, Marina Alonzoa Immunogenomics and Inflammation Research Team, University of Lyon, Edouard Herriot Hospital, Lyon, FranceView further author information
, Cécile Barontic Unité des Virus Émergents (UVE: Aix-Marseille University - IRD 190 - Inserm 1207), Marseille, FranceView further author information
, Sandie Muniere Institut Pasteur, Université Paris Cité, CNRS UMR3569, Molecular Genetics of RNA Viruses Unit, Paris, FranceView further author information
, Mikaël Attiae Institut Pasteur, Université Paris Cité, CNRS UMR3569, Molecular Genetics of RNA Viruses Unit, Paris, FranceView further author information
, Xavier de Lamballeriec Unité des Virus Émergents (UVE: Aix-Marseille University - IRD 190 - Inserm 1207), Marseille, FranceView further author information
, Tristan Ferryf Department of Infectious and Tropical Diseases, Hospices Civils of Lyon - Croix-Rousse Hospital, Lyon, France;g CIRI, Inserm U1111, CNRS, UMR5308, ENS Lyon, Université Claude Bernard Lyon I, Lyon, FranceView further author information
& Pierre Miosseca Immunogenomics and Inflammation Research Team, University of Lyon, Edouard Herriot Hospital, Lyon, France;h Department of Immunology and Rheumatology, Edouard Herriot Hospital, Lyon, FranceView further author information
show all
Article: 2307510
|
Received 03 Oct 2023, Accepted 16 Jan 2024, Published online: 30 Jan 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.